Educational information, not medical advice — ask your doctor or midwife.
Track N-Acetyl Glucosamine with reminders and record whether it helped, in the app.
N-Acetyl Glucosamine (NAG) is a modified form of the simple sugar glucosamine that your body naturally produces and uses as a building block for some of its most important structural tissues. Unlike plain glucosamine sulfate, NAG has an acetyl group attached that makes it more readily absorbed and directly usable by cells in your joints, gut lining, and skin. It is a key component of hyaluronic acid, glycosaminoglycans, and mucins — the molecules that keep joints cushioned, gut walls intact, and skin plump.
NAG feeds directly into the biosynthesis of hyaluronic acid, the gel-like molecule that lubricates joints and retains moisture in skin. In the gut, it supports the production of mucins — the protective mucus layer that lines the intestinal wall and shields it from harmful bacteria and inflammation. In joints, it helps rebuild the cartilage matrix and may dampen inflammatory signaling, slowing the breakdown that comes with wear and aging.
Oral capsules and tablets are the most studied forms for joint and gut benefits, typically standardized to 500–1000 mg NAG per serving. Powder forms are useful for those who want to adjust doses. Topical serums and creams containing 2–5% NAG are used specifically for skin brightening, hydration, and reducing hyperpigmentation, and are well studied in dermatology.
NAG is a relatively modern nutritional supplement — its clinical investigation began in earnest in the 1990s and 2000s as researchers sought alternatives or complements to glucosamine sulfate for joint health. Its gut applications emerged from gastroenterology research in the early 2000s, and dermatology research followed as the cosmetic industry recognized its role in skin hydration and tone.
Evidence grades and traditional-use labels are explained in our methodology. Nothing here is medical advice.
What it is typically used for, usual dose, cautions, and the study behind it where real trial data exists.
One email with the summary. We'll also send a short weekly evidence update — unsubscribe any time.